PALM BEACH, Fla.—The initial results of an ongoing first-in-man study in Colombia that saw the implantation of a prosthetic venous valve in 15 patients appear promising, with improvement in clinical outcomes and quality of life evaluation, delegates at the Southern Association for Vascular Surgery (SAVS) annual meeting (Jan. 8–11) here heard.
There was also a marked reduction in pain among a complex and difficult-to-treat patient population, trial investigator Jorge H. Ulloa, MD, of Universidad de los Andes in Bogota, Colombia, told the scientific session.